Discover
CTSO
Cytosorbents Corporation
3.79
2 x 3.09
2 x 5.06
bid
ask
+
0.06
1.61%
2 @ 04:00 PM
3.79 +0.00 (0.00%)
| Ytd | -70.34% | |
| 1y | -79.67% |
3.59
day range
3.80
3.73
52 week range
18.64
| Open | 3.67 | Prev Close | 3.73 | Low | 3.59 | High | 3.80 | Mkt Cap | 11.94M |
| Vol | 6.23K | Avg Vol | 12.45K | EPS | -5.79 | P/E | N/A | Forward P/E | -5.99 |
| Beta | 0.56 | Short Ratio | 9.57 | Inst. Own | 33.29% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 6.21 | 200-d Avg | 10.23 | 1yr Est | 5.00 |
| Income Statement | |||
| Total Revenue | 9.63M | ||
| Revenues (USD) | 9.63M | ||
| Cost of Revenue | 2.58M | ||
| Gross Profit | 7.05M | ||
| Operating Expenses | 9.69M | ||
| Research and Development Expense | 1.45M | ||
| Selling, General and Administrative Expense | 7.96M | ||
| Operating Income | -2.64M | ||
| Interest Expense | 868.00K | ||
| Net Income | -4.42M | ||
| Net Income Common Stock | -4.42M | ||
| Net Income Common Stock (USD) | -4.42M | ||
| Consolidated Income | -4.42M | ||
| Earnings per Basic Share | -1.40 | ||
| Earnings per Basic Share (USD) | -1.40 | ||
| Earnings per Diluted Share | -1.40 | ||
| Earning Before Interest & Taxes (EBIT) | -3.55M | ||
| Earning Before Interest & Taxes (USD) | -3.55M | ||
| Weighted Average Shares | 3.14M | ||
| Weighted Average Shares Diluted | 3.14M | ||
| Balance Sheet | |||
| Cash and Equivalents | 5.94M | ||
| Cash and Equivalents (USD) | 5.94M | ||
| Trade and Non-Trade Receivables | 6.79M | ||
| Current Assets | 15.74M | ||
| Property, Plant & Equipment Net | 17.78M | ||
| Total Assets | 37.96M | ||
| Debt Current | 14.15M | ||
| Total Debt | 28.84M | ||
| Current Liabilities | 24.02M | ||
| Debt Non-Current | 14.69M | ||
| Total Liabilities | 38.71M | ||
| Accumulated Retained Earnings (Deficit) | -321.75M | ||
| Accumulated Other Comprehensive Income | -996.00K | ||
| Shareholders Equity | -751.00K | ||
| Shareholders Equity (USD) | -751.00K | ||
| Assets Non-Current | 22.22M | ||
| Total Debt (USD) | 28.84M | ||
| Goodwill and Intangible Assets | 2.86M | ||
| Inventory | 3.69M | ||
| Liabilities Non-Current | 14.69M | ||
| Trade and Non-Trade Payables | 2.00M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 314.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -400.00K | ||
| Capital Expenditure | 45.00K | ||
| Net Cash Flow from Investing | 7.00K | ||
| Net Cash Flow from Operations | -583.00K | ||
| Effect of Exchange Rate Changes on Cash | 176.00K | ||
| Share Based Compensation | 368.00K | ||